A Rare U.S. Case of Andes Virus: What Happened and What It Means

In February 2018, the Centers for Disease Control and Prevention identified the first case of Andes virus in the United States. The patient had recently returned to Delaware from travel to Argentina and Chile, where he had been from December 20, 2017, through January 3, 2018. This marked the first time the virus had been brought into the country—an event that triggered the CDC's standard protocol for tracking disease spread.

The case set off alarm bells partly because of how the virus works. The CDC traced the steps of two people at heightened risk: a healthcare worker who came into contact with the patient's sweat, and a family member who handled the patient's clothes and bedding. This level of attention reflects a key fact about Andes virus: unlike most hantaviruses, it can spread from person to person, at least in close contact settings.

How Andes Virus Spreads, and Why It Matters

Andes virus is a member of the hantavirus family, a group of viruses that are typically carried and spread by rodents. Most hantaviruses are spread mainly through contact with infected rodents or their droppings. Andes virus is unusual because it has shown an ability to jump from one person to another.

The catch: the person-to-person spread is limited. It mainly occurs between people in close contact with someone who is sick. This puts it in a different category than the hantavirus strains found in North America, which do not spread between people at all.

In the Delaware case, the exposure pathways—sweat and contaminated personal items—matched what public health experts already knew about how the virus travels from person to person. This prior knowledge helped the CDC decide which contacts posed a real risk and which did not.

A Pattern From South America

The 2018 Delaware case was not the first alarm. Between July 1997 and January 1998, an outbreak of 25 cases struck southern Chile, all caused by Andes virus. That outbreak showed scientists that the virus could sustain itself in a population over weeks and months. More recently, the WHO issued an alert about hantavirus in Argentina on January 23, 2019, signaling that the virus remains active in these regions.

People traveling to Argentina and Chile—especially to rural or remote areas where rodents are common—can be exposed to the virus in nature. The infections happen when travelers come into contact with infected rodents or their droppings.

Over the decades, we have seen imported infectious diseases arrive in the United States this way before. What distinguishes Andes virus is that extra layer: once someone brings it in, it can spread between people. That calls for more careful contact tracing than would be needed for a virus that only spreads through rodent contact.

The Public Health Response

The fact that the CDC caught and investigated this case quickly speaks to how disease surveillance systems work. Hospitals and labs in the United States are trained to recognize and test for unusual respiratory illnesses, especially in patients who have traveled to countries where these diseases circulate. That detection capability is part of what allowed the first Andes case to be identified at all.

The contact tracing investigation found no secondary cases—neither the healthcare worker nor the family member went on to develop the illness. This outcome lined up with what the CDC expected, given what is known about how rarely person-to-person transmission actually occurs. It also meant the investigation had done what it was meant to do: contain the threat before it spread.

What This Means for Travel and Healthcare

For anyone traveling to Argentina or Chile, particularly in wilderness areas, the lesson is straightforward: avoid contact with rodents and their droppings. Keep food properly sealed if camping or spending time outdoors. These are common-sense precautions that reduce your odds of infection.

For doctors and nurses, the case reinforced the importance of asking patients about where they have traveled, especially when they come in with severe respiratory symptoms. It also signaled the need for proper infection control measures—precautions that account for the possibility of person-to-person spread—when treating suspected or confirmed Andes virus cases.

The successful containment of this imported case—with no further spread—shows that the system in place works. Global surveillance networks can spot new threats at the border, and contact tracing protocols, when properly applied, can stop an outbreak before it starts. The absence of secondary cases validated both the clinical judgment and the epidemiological understanding that went into the response.

This case is routine in one sense: it is exactly the sort of imported infectious disease that public health agencies manage year after year. But it also represents an important reminder that disease surveillance and rapid response are not luxuries; they are core tools for keeping a global population safe.